CONDUIT PHARMACEUTICALS INC (CDT) Stock Cash Flow
NASDAQ:CDT - Nasdaq - US20678X2053 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.40M | -17.80M | -535.00K | -4.89M | -3.66M | |||
| Depreciation Amortization | N/A | 457.00K | N/A | N/A | N/A | |||
| Change In Working Capital | -1.15M | -142.00K | -2.52M | 596.00K | 1.36M | |||
| Other non cash items | 8.25M | 7.80M | -4.67M | 2.02M | 149.00K | |||
| OPERATING CASH FLOW | -11.65M | -9.68M | -7.72M | -2.27M | -2.15M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -51.00K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | 8.00K | 725.00K | -183.00K | 0.00 | |||
| INVESTING CASH FLOW | -47.00K | -43.00K | 725.00K | -183.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 2.45M | 2.29M | 1.11M | 688.00K | |||
| Stock Issued/Repurchased | N/A | 3.62M | N/A | 1.34M | 1.21M | |||
| Other Financing Activity | N/A | N/A | 8.64M | -3.11M | -50.00K | |||
| FINANCING CASH FLOW | 11.99M | 6.07M | 10.93M | 2.45M | 1.90M | |||
| Exchange Rate Effect | -7.00K | -16.00K | 299.00K | 1.00K | 1.00K | |||
| CHANGE IN CASH | 286.00K | -3.67M | 4.23M | 0.00 | -252.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.65M | -9.68M | -7.72M | -2.27M | -2.15M | |||
| Capital Expenditure | N/A | -51.00K | N/A | N/A | N/A | |||
| FREE CASH FLOW | -11.71M | -9.73M | -7.72M | -2.27M | -2.15M | |||
All data in USD